Mumbai, India, March ninth, 2022 – Thermo Fisher Scientific launched its newest technology of SeqStudio Flex Series Genetic Analyzer to allow prospects’ cutting-edge analysis in areas reminiscent of gene modifying and infectious illness. Capillary Electrophoresis (CE), which permits Sanger Sequencing and fragment evaluation is a crucial software for enhancing scientific analysis and advancing scientific discovery. The SeqStudio Flex Genetic Analyzer delivers the gold-standard high quality of CE know-how with correct knowledge and dependable efficiency.
“At Thermo Fisher we strive to provide innovative and advanced products that meet the needs of our customers. The SeqStudio Flex Series Genetic Analyzers are designed keeping our customers in mind, offering a simplified, more efficient workflow, multiple applications and an exceptional level of accuracy to advance their research. The introduction of the product reaffirms our commitment to innovation and our investments in CE technology expands our portfolio with the latest generation of innovative, mid-throughput genetic analyzers,” mentioned Amit Chopramanaging director, India, and South Asia, Thermo Fisher Scientific.
The new mid-throughput genetic analyzer introduces design and technological developments for enhanced flexibility, usability and connectivity. The instrument has elevated plate capability and could also be loaded at any time with out canceling or ready for a run to finish, enhancing pattern throughput and walk-away capability and scheduling flexibility.
English
Arabic
Bengali
Chinese (Simplified)
Dutch
Finnish
French
German
Gujarati
Hindi
Italian
Marathi
Portuguese
Russian
Spanish
Tamil
Telugu